Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmuCell Corp (NASDAQ:ICCC)

10.60
Delayed Data
As of 3:59pm ET
 +1.59 / +17.65%
Today’s Change
3.96
Today|||52-Week Range
10.74
+118.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$27.3M

Company Description

ImmuCell Corp. is a biotechnology company, which develops, manufactures and sells products to improve animal health and productivity in the dairy and beef industry. Its products focuses on encompasses prevention, diagnosis and treatment of economically important bovine diseases. ImmuCell was founded by Frank E. Ruch in 1982 and is headquartered in Portland, ME.

Contact Information

ImmuCell Corp.
56 Evergreen Drive
Portland Maine 04103
P:(207) 878-2770
Investor Relations:

Employees

Shareholders

Other institutional7.83%
Individual stakeholders30.08%
Mutual fund holders0.53%

Top Executives

Michael F. BrighamPresident, CEO, CFO, Secretary & Treasurer
Joseph H. CrabbDirector, Chief Scientific Officer & VP
Bobbi Jo BrockmannVice President-Sales & Marketing